Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × apatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 54 Carcinoma, Hepatocellular 39 Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 18 Ovarian Neoplasms 17 Colorectal Neoplasms 15 Breast Neoplasms 13 Sarcoma 12 Triple Negative Breast Neoplasms 11 Nasopharyngeal Carcinoma 11 Neoplasms 10 Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 9 Cholangiocarcinoma 9 Neoplasm Metastasis 7 Lung Neoplasms 7 Advanced Gastric Cancer 7 Squamous Cell Carcinoma of Head and Neck 6 Recurrence 6 Osteosarcoma 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Uterine Cervical Neoplasms 5 Liver Neoplasms 5 Solid Tumor 4 Pancreatic Neoplasms 4 Melanoma 4 Glioma 4 Thyroid Neoplasms 3 NSCLC 3

Interventions

Paclitaxel 79 Carboplatin 63 pembrolizumab 57 Bevacizumab 24 Cisplatin 23 Surveys and Questionnaires 20 Radiotherapy 19 Letrozole 19 Doxorubicin 18 olaparib 17 Megestrol Acetate 17 lenvatinib 16 Specimen Handling 16 dostarlimab 15 Taxes 15 Nivolumab 14 Observation 13 Metformin 13 Magnetic Resonance Spectroscopy 13 Docetaxel 13 Fulvestrant 11 Blood Specimen Collection 11 durvalumab 10 Medroxyprogesterone Acetate 10 Brachytherapy 10 Biopsy 10 temsirolimus 9 abemaciclib 9 Trastuzumab 9 Radiation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06771154 2025-01-13

A-CAPE

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡